Ferrokin Biosciences, Inc.
Records under this name other than patents Ferrokin Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Ferrokin Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,512,095 | Polymorph forms of desazadesferrithiocin analogs Lapsed on the fee record Ended Dec 6, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 6, 2020 | USPTO record |
| US 8,063,227 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents Lapsed on the fee record Ended Nov 22, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 22, 2019 | USPTO record |
| US 9,045,440 | Desazadesferrothiocin and Desazadesferrothiocin Polyether Analogues as Metal Chelation Agents Lapsed on the fee record Ended Jun 2, 2019 · High confidence | Lapsed on the fee record | Ended Jun 2, 2019 | High confidence |
| US 8,993,606 | Oral formulations for treating metal overload Lapsed on the fee record Ended Mar 31, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 31, 2019 | USPTO record |
| US 8,846,731 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents Lapsed on the fee record Ended Sep 30, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 30, 2018 | USPTO record |
| US 8,829,197 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents Lapsed on the fee record Ended Sep 9, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2018 | USPTO record |
| US 8,710,087 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents Lapsed on the fee record Ended Apr 29, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2018 | USPTO record |